Home
At the heart of successful Pathology Labs
.
About Epredia
85 Years of Improving Lives through Enhancing Precision Diagnostics
Your expertise, our shared mission. Take a closer look at the trusted tools that form the foundation for excellence in cancer diagnostics.
News
Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx™ Digital Pathology Solution
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 Dx Digital Pathology Solution (E1000 Dx). Read More